Local: Los Angeles, CA  (change)

 | 

Join the Topix community today: 

Sign Up

 | 

Sign In

Advertisment

Teva Pharmaceutical Industries News

News on Teva Pharmaceutical Industries continually updated from thousands of sources around the net.

3 hrs ago | Barron's

A Prime Candidate for Call Buying

Might be time to buy calls of Teva Pharmaceutical, the world's leading generic-drug maker.

Comment?

Related Topix: Biotech, Investment Banking, Financial Services, Goldman Sachs Group, Investment Services

Tue Aug 19, 2008

The South Mississippi Sun Herald

CEL-SCI Announces Exclusive Licensing Agreement with Teva for Cancer Drug Multikine

SCI Corporation announced today that it has entered into an exclusive licensing agreement with Teva Pharmaceutical Industries Ltd.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Cancer, Health

Mon Aug 18, 2008

CFO

The Rules that Launched 1,000 Deals?

A recent cross-border merger met some thorny IRS requirements including passing the Helen of Troy test to capture tax-free status as a reorganization.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Montvale, NJ, Barr Laboratories

Sat Aug 16, 2008

Motley Fool

The Best Stocks of the Millennium

What have been the best stocks to own in this new millennium, by all accounts the most Britney-filled of all the millennia on record so far? And what, if anything, can we learn by simply running a couple of ...

Comment?

Related Topix: Financial Markets, Biotech

Fri Aug 15, 2008

International Herald Tribune

Consumer goods firms and exporters lead rally in European stocks

LONDON : European stocks rose Friday, led by consumer-goods companies, as falling commodity prices eased concern that inflation would force central banks to lift interest rates.

Comment?

Related Topix: Biotech, Financial Markets

Wed Aug 13, 2008

Blogging Stocks

Serious Money: 'Stable stocks' update - CB, DIS, JNJ, TEVA & XEL

Well, the market was in the dumps yesterday and is even worse today. So this may be a good time to check on my list of stocks for those looking for equities that are stable enough to ride out this bearish ...

Comment?

Related Topix: Biotech, Financial Markets, Xcel Energy, Energy, Media, Walt Disney, Television, Johnson and Johnson, Medicine, Healthcare Industry

Fri Aug 08, 2008

The Jersey Journal

Continue reading "Par Pharmaceutical posts loss, cuts full-year outlook"

Shares of Par Pharmaceutical plunged today after the generic drug developer reported a second-quarter loss and slashed its outlook because of tougher competition and pricing pressure.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Woodcliff Lake, NJ, Montvale, NJ, Barr Laboratories

Wed Aug 06, 2008

The Motley Fool

The Next 5 Stocks to Buy?

There are some 24 million Americans afflicted with diabetes, according to the American Diabetes Association, and it's estimated an additional 1 million cases are reported each year at a cost to public health of ...

Comment?

Related Topix: Medicine, Diabetes, Health, Biotech, DepoMed, Startups

Tue Aug 05, 2008

US News & World Report

5 ETFs Defying the Market Doldrums

Gary Gordon, author of the ETF Expert blog, highlights an eclectic mix of exchange-traded funds that have posted gains so far this year despite the down market: 1. iShares Biotechnology Fund .

Comment?

Related Topix: Biotech, Science / Technology

Mon Aug 04, 2008

Bloomberg.com

Wyeth Says It Received Added Subpoenas in Massachusetts Protonix Inquiry

Wyeth received additional subpoenas from a U.S. grand jury in Massachusetts investigating the marketing and pricing of the heartburn drug Protonix.

Comment?

Related Topix: Marketing, Biotech

Sun Aug 03, 2008

MarketWatch

Israel Stocks: Market's mixed; Teva beats estimate and shares decline

Israeli stocks closed mixed on Tuesday as investors chewed over Teva's earnings report and the Bank of Israel's third straight quarter-point rate increase.

Comment?

Related Topix: Israel, World News, Financial Markets, Biotech

Fri Aug 01, 2008

Market Watch

CORRECT: Teva posts higher profit, boosted by Copaxone sales

The Israeli generic drugmaker posted net income of $539 million, or 65 cents a share, compared with $515 million, or 63 cents.

Comment?

Related Topix: Biotech

Thu Jul 31, 2008

MarketWatch

Corrections: Market's mixed; Teva beats estimate and shares drop

Market's mixed; Teva beats estimate and shares drop - MarketWatch Intraday data provided by Interactive Data Real Time Services , a division of Interactive Data Corp.

Comment?

Related Topix: Biotech, Media, Interactive Data, Computers, IT Services

SchaeffersResearch.com Daily Market Blog

Teva Pharmaceuticals (TEVA) Slips on Second-Quarter Report

For the quarter, TEVA reported net income of $539 million, or 65 cents per share, compared with $515 million, or 63 cents, last year.

Comment?

Related Topix: Biotech, Financial Markets, Personal Finance, Day Trading

Wed Jul 30, 2008

MarketWatch

Israel Stocks: Market higher; Alvarion and AudioCodes ahead

Israeli stocks finished higher Wednesday, with Teva Pharmaceutical and a handful of tech companies getting good analyst reviews, Alvarion Ltd.

Comment?

Related Topix: Alvarion, Financial Markets, Computers, Israel, World News, Biotech

Earth Times

Antares Pharma and Teva Announce Filing of sNDA for Needle-Free Injector with Human Growth Hormone

Antares Pharma, Inc. , a specialty pharmaceutical company focused on improving pharmaceuticals through advanced drug delivery systems, and its partner, Teva Pharmaceutical Industries Ltd.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Medical Equipment

Earth Times

Antares Pharma and Teva Announce Filing of sNDA for Needle-Free Injector with Human Growth Hormone

Antares Pharma, Inc. , a specialty pharmaceutical company focused on improving pharmaceuticals through advanced drug delivery systems, and its partner, Teva Pharmaceutical Industries Ltd.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Medical Equipment

Tue Jul 29, 2008

Earth Times

Antares Pharma and Teva Announce Filing of sNDA for Needle-Free Injector with Human Growth Hormone

Antares Pharma, Inc. , a specialty pharmaceutical company focused on improving pharmaceuticals through advanced drug delivery systems, and its partner, Teva Pharmaceutical Industries Ltd.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Medical Equipment

Earth Times

Antares Pharma and Teva Announce Filing of sNDA for Needle-Free Injector with Human Growth Hormone

Antares Pharma, Inc. , a specialty pharmaceutical company focused on improving pharmaceuticals through advanced drug delivery systems, and its partner, Teva Pharmaceutical Industries Ltd.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Medical Equipment

Med Ad News

Teva Reports Second Quarter 2008 Results

Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended June 30, 2008.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry

↑ Back to top

More Teva Pharmaceutical Industries News

Archives

Read more articles in the Teva Pharmaceutical Industries News Archives.

For up to the minute news, check out the Teva Pharmaceutical Industries News Wire.

Want to add Teva Pharmaceutical Industries News headlines to your web site? Get the widget here.

Teva Pharmaceutical Industries News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Teva Pharmaceutical Industries News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Teva Pharmaceutical Industries Photos

Topix Quick Poll

created by: Bay Hiro | Sunday Jul 27

Click on an option to vote

268

votes

  • 50-100 miles?
  • 100-300 miles?
  • 500+ miles?

Los Angeles Jobs